Literature DB >> 23027864

Botulinum neurotoxin serotype C associates with dual ganglioside receptors to facilitate cell entry.

Andrew P-A Karalewitz1, Zhuji Fu, Michael R Baldwin, Jung-Ja P Kim, Joseph T Barbieri.   

Abstract

BACKGROUND: How botulinum neurotoxin serotype C (BoNT/C) enters neurons is unclear.
RESULTS: BoNT/C utilizes dual gangliosides as host cell receptors.
CONCLUSION: BoNT/C accesses gangliosides on the plasma membrane. SIGNIFICANCE: Plasma membrane accessibility of the dual ganglioside receptors suggests synaptic vesicle exocytosis may not be necessary to expose BoNT/C receptors. Botulinum neurotoxins (BoNTs) cleave SNARE proteins in motor neurons that inhibits synaptic vesicle (SV) exocytosis, resulting in flaccid paralysis. There are seven BoNT serotypes (A-G). In current models, BoNTs initially bind gangliosides on resting neurons and upon SV exocytosis associate with the luminal domains of SV-associated proteins as a second receptor. The entry of BoNT/C is less clear. Characterizing the heavy chain receptor binding domain (HCR), BoNT/C was shown to utilize gangliosides as dual host receptors. Crystallographic and biochemical studies showed that the two ganglioside binding sites, termed GBP2 and Sia-1, were independent and utilized unique mechanisms to bind complex gangliosides. The GBP2 binding site recognized gangliosides that contained a sia5 sialic acid, whereas the Sia-1 binding site recognized gangliosides that contained a sia7 sialic acid and sugars within the backbone of the ganglioside. Utilizing gangliosides that uniquely recognized the GBP2 and Sia-1 binding sites, HCR/C entry into Neuro-2A cells required both functional ganglioside binding sites. HCR/C entered cells differently than the HCR of tetanus toxin, which also utilizes dual gangliosides as host receptors. A point-mutated HCR/C that lacked GBP2 binding potential retained the ability to bind and enter Neuro-2A cells. This showed that ganglioside binding at the Sia-1 site was accessible on the plasma membrane, suggesting that SV exocytosis may not be required to expose BoNT/C receptors. These studies highlight the utility of BoNT HCRs as probes to study the role of gangliosides in neurotransmission.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23027864      PMCID: PMC3504792          DOI: 10.1074/jbc.M112.404244

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Translocation of botulinum neurotoxin light chain protease through the heavy chain channel.

Authors:  Lilia K Koriazova; Mauricio Montal
Journal:  Nat Struct Biol       Date:  2003-01

2.  Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid. Novel insights into the receptor for clostridial neurotoxins.

Authors:  Kentaro Tsukamoto; Tomoko Kohda; Masafumi Mukamoto; Kumiko Takeuchi; Hideshi Ihara; Masaki Saito; Shunji Kozaki
Journal:  J Biol Chem       Date:  2005-08-22       Impact factor: 5.157

3.  Coot: model-building tools for molecular graphics.

Authors:  Paul Emsley; Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

4.  STED microscopy reveals that synaptotagmin remains clustered after synaptic vesicle exocytosis.

Authors:  Katrin I Willig; Silvio O Rizzoli; Volker Westphal; Reinhard Jahn; Stefan W Hell
Journal:  Nature       Date:  2006-04-13       Impact factor: 49.962

5.  SV2 is the protein receptor for botulinum neurotoxin A.

Authors:  Min Dong; Felix Yeh; William H Tepp; Camin Dean; Eric A Johnson; Roger Janz; Edwin R Chapman
Journal:  Science       Date:  2006-03-16       Impact factor: 47.728

Review 6.  Botulinum toxin as a biological weapon: medical and public health management.

Authors:  S S Arnon; R Schechter; T V Inglesby; D A Henderson; J G Bartlett; M S Ascher; E Eitzen; A D Fine; J Hauer; M Layton; S Lillibridge; M T Osterholm; T O'Toole; G Parker; T M Perl; P K Russell; D L Swerdlow; K Tonat
Journal:  JAMA       Date:  2001-02-28       Impact factor: 56.272

Review 7.  Glycosphingolipids-sweets for botulinum neurotoxin.

Authors:  Brian C Yowler; Cara-Lynne Schengrund
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

8.  Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G.

Authors:  Andreas Rummel; Tino Karnath; Tina Henke; Hans Bigalke; Thomas Binz
Journal:  J Biol Chem       Date:  2004-04-30       Impact factor: 5.157

9.  Botulinum neurotoxin A blocks synaptic vesicle exocytosis but not endocytosis at the nerve terminal.

Authors:  E A Neale; L M Bowers; M Jia; K E Bateman; L C Williamson
Journal:  J Cell Biol       Date:  1999-12-13       Impact factor: 10.539

10.  Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin.

Authors:  G Schiavo; F Benfenati; B Poulain; O Rossetto; P Polverino de Laureto; B R DasGupta; C Montecucco
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

View more
  19 in total

1.  Tetanus neurotoxin utilizes two sequential membrane interactions for channel formation.

Authors:  Joshua R Burns; Michael R Baldwin
Journal:  J Biol Chem       Date:  2014-06-27       Impact factor: 5.157

Review 2.  Botulinum neurotoxins: genetic, structural and mechanistic insights.

Authors:  Ornella Rossetto; Marco Pirazzini; Cesare Montecucco
Journal:  Nat Rev Microbiol       Date:  2014-06-30       Impact factor: 60.633

3.  A Heterologous Reporter Defines the Role of the Tetanus Toxin Interchain Disulfide in Light-Chain Translocation.

Authors:  Madison Zuverink; Chen Chen; Amanda Przedpelski; Faith C Blum; Joseph T Barbieri
Journal:  Infect Immun       Date:  2015-04-20       Impact factor: 3.441

Review 4.  Dissecting the Role of Anti-ganglioside Antibodies in Guillain-Barré Syndrome: an Animal Model Approach.

Authors:  Pallavi Asthana; Joaquim Si Long Vong; Gajendra Kumar; Raymond Chuen-Chung Chang; Gang Zhang; Kazim A Sheikh; Chi Him Eddie Ma
Journal:  Mol Neurobiol       Date:  2015-09-15       Impact factor: 5.590

Review 5.  Diverse binding modes, same goal: The receptor recognition mechanism of botulinum neurotoxin.

Authors:  Kwok-Ho Lam; Guorui Yao; Rongsheng Jin
Journal:  Prog Biophys Mol Biol       Date:  2015-02-19       Impact factor: 3.667

6.  Molecular landscape of BoNT/B bound to a membrane-inserted synaptotagmin/ganglioside complex.

Authors:  Jorge Ramirez-Franco; Fodil Azzaz; Marion Sangiardi; Géraldine Ferracci; Fahamoe Youssouf; Michel Robert Popoff; Michael Seagar; Christian Lévêque; Jacques Fantini; Oussama El Far
Journal:  Cell Mol Life Sci       Date:  2022-08-25       Impact factor: 9.207

7.  Synaptotagmin II and gangliosides bind independently with botulinum neurotoxin B but each restrains the other.

Authors:  M Zouhair Atassi; Midori Taruishi; Masooma Naqvi; Lance E Steward; K Roger Aoki
Journal:  Protein J       Date:  2014-06       Impact factor: 2.371

8.  Entry of a recombinant, full-length, atoxic tetanus neurotoxin into Neuro-2a cells.

Authors:  Faith C Blum; Amanda Przedpelski; William H Tepp; Eric A Johnson; Joseph T Barbieri
Journal:  Infect Immun       Date:  2013-12-09       Impact factor: 3.441

9.  Crystal structures of botulinum neurotoxin DC in complex with its protein receptors synaptotagmin I and II.

Authors:  Ronnie Per-Arne Berntsson; Lisheng Peng; Linda Marie Svensson; Min Dong; Pål Stenmark
Journal:  Structure       Date:  2013-08-08       Impact factor: 5.006

10.  CRISPR/Cas9-Mediated Genomic Deletion of the Beta-1, 4 N-acetylgalactosaminyltransferase 1 Gene in Murine P19 Embryonal Carcinoma Cells Results in Low Sensitivity to Botulinum Neurotoxin Type C.

Authors:  Kentaro Tsukamoto; Chikako Ozeki; Tomoko Kohda; Takao Tsuji
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.